AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Imatinib in South Africa
1 product registered with SAHPRA — 0 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| VATIVIO 100 | 36/34/0139 | Novartis South Africa (Pty) Ltd | suspended | 7 Aug 2024 |
Imatinib — SAHPRA Registration Details
SAHPRA (South Africa) has 1 registered product containing Imatinib, of which 0 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Imatinib registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.